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There is increasing evidence that G-protein-coupled
receptors cross-talk with growth factor receptor-
mediated signal transduction in a variety of cell types.
We have investigated mechanisms by which the activa-
tion of b-adrenergic receptors, classically GTP-binding
proteins coupled receptors, in£uence the migration
of cultured human keratinocytes. We found that iso-
proterenol, a b-adrenergic receptor-selective agonist,
inhibited cell migration stimulated by either epidermal
growth factor, or extracellular Ca2þ in a concentration-
dependent manner. This was prevented by pretreat-
ment of the cells with the b-adrenergic receptor-selec-
tive antagonist timolol. Interestingly, isoproterenol,
at a concentration of 1 nM, did not measurably increase
intracellular cyclic adenosine monophosphate con-
centrations yet inhibited cell migration by 50%. To
test further if isoproterenol’s actions were mediated
via activation of adenylyl cyclase, two inhibitors of
its activity, 2050 -dideoxyadenosine and SQ22536, were
used. Both compounds signi¢cantly diminished iso-
proterenol-induced increases in intracellular cyclic
adenosine monophosphate concentrations but did
not attenuate isoproterenol-induced inhibition of cell
migration. Also, forskolin (1 lM) markedly increased
intracellular cyclic adenosine monophosphate con-
centrations but did not signi¢cantly inhibit cell
migration. As mitogen-activated protein kinases
are known to signal growth factor-stimulated cell mi-
gration, we examined whether b-adrenergic receptor-
mediated inhibition of keratinocyte migration might
occur via inactivation of mitogen-activated protein
kinases. We found that isoproterenol inhibited phos-
phorylation of extracellular signal-regulated kinase
mitogen-activated protein kinase in a concentration-
dependent manner but had no e¡ect on the phosphory-
lation of the stress mitogen-activated protein kinases
c-jun N-terminal kinase and stress-activated protein
kinase-2. Neither forskolin nor a membrane perme-
able cyclic adenosine monophosphate analog inhibited
phosphorylation of any of these mitogen-activated pro-
tein kinases. These ¢ndings suggest that b-adrenergic
receptor-induced inhibition of keratinocyte migration
is mediated through inhibition of the extracellular sig-
nal-regulated kinase mitogen-activated protein kinase
signaling in a cyclic adenosine monophosphate-inde-
pendent manner. Key words: cell motility/isoproterenol/
wound healing. J Invest Dermatol 119:1261 ^1268, 2002
K
eratinocyte migration plays an important part in
re-epithelialization and skin wound healing (Hunt
et al, 2000). Cell migration is a multistep cellular
process that is regulated by complex extracellular
and intracellular signals (Muyderman et al, 2001).
The regulation of migration by growth factors such as epidermal
growth factor (EGF), transforming growth factor-b, keratinocyte
growth factor, and ¢broblast growth factor has been extensively
studied during the last decade in many cell types, including ker-
atinocytes (Hudson and McCawley, 1998; Jaakkola et al, 1998). The
motogenic signaling pathways for these growth factors have been
found to overlap with mitogenic signaling pathways (Klemke
et al, 1997; Cho and Klemke, 2000; Kain and Klemke, 2001);
however, little is known about the role of G-protein-coupled re-
ceptors (GPCR) in the regulation of keratinocyte migration and
re-epithelialization. Recent studies have shown that G-protein bg
or g subunits modulate stress ¢ber formation and focal adhesion
assembly in ¢broblasts and HeLa cells (Ueda et al, 1999, 2000);
these ¢ndings suggest that GPCR may play an important part
in the modulation of cell migration. It is well documented that
in many cell types, GPCR cross-talk widely with the growth fac-
tor receptor-mediated signaling pathway: migration-related pro-
tein kinases such as mitogen-activated protein (MAP) kinases,
phosphatidylinositol-3 kinase, and tyrosine kinases, and small
GTP-binding proteins, such as Rho family members (Yamauchi
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et al, 1997; Lopez-Ilasaca, 1998; Luttrell et al, 1999a; Grewal et al,
2001; Pierce et al, 2001) can all be activated by GPCR.These ¢nd-
ings suggest that GPCR may also play important parts in moto-
genesis as they do in mitogenesis.
b-adrenergic receptors activate stimulatory GTP-binding
proteins (Gs proteins), which in turn activate adenylyl cyclase,
leading to an increase in intracellular cyclic adenosine
monophosphate (cAMP) concentrations and activation of protein
kinase A (PKA). More recently, it has become clear that some of
the cellular functions mediated by these receptors are indepen-
dent of adenylyl cyclase activation and rather involve other med-
iators. The Gsa and Gsbg subunits themselves may interact with
other e¡ectors, such as other protein kinases and ion channel
members of the mitogenic/stress signaling pathways; conversely
these receptors may function in a G-protein-independent manner
(Bishopric et al, 1992; Iwaki et al, 1990; Bogoyevitch et al, 1996;
Hall et al, 1998; Lefkowitz, 1998; Brzostowski and Kimmel,
2001).
Expression of b-adrenergic receptors by human keratinocytes
was demonstrated many years ago (Harper and Flaxman, 1975;
Orenberg et al, 1983), and a correlation between increases in intra-
cellular cAMP concentration induced by receptor activation and
cellular responses involving proliferation and migration has been
proposed (Harper and Flaxman, 1975; Dunlap, 1980; Donaldson
and Mahan, 1984). It is not clear, however, that these responses
are indeed mediated by changes in intracellular cAMP concentra-
tions.
Virtually nothing is known about the role of b-adrenergic re-
ceptors in modulating human keratinocyte migration and re-
epithelialization during skin wound healing. This may be of
clinical importance because many patients are treated with
b-adrenergic receptor agonists and antagonists, e.g., for asthma
and hypertension, respectively. If b-adrenergic receptors alter cell
migration, wound healing in patients using these drugs may be
in£uenced in a variety of clinical settings. In this study,
we investigated the e¡ects of b-adrenergic receptor activation
on growth factor-mediated keratinocyte migration.We made the
unexpected observation that migration is markedly inhibited by
the b-adrenergic receptor agonist isoproterenol, and that the in-
hibition is independent of the simultaneous accumulation of
cAMP induced by activation of these receptors. Consequently,
further experiments were designed to investigate the e¡ector
pathways that modulate the inhibition of migration by b-adre-
nergic receptor agonists in these cells.
MATERIALS AND METHODS
Materials Isoproterenol and timolol were from Sigma (St Louis, MO).
20,50 -dideoxyadenosine (DDA), SQ22536, and pertussis toxin were
purchased from Calbiochem Co. (La Jolla, CA). Antibodies against
phosphorylated extracellular signal-regulated kinase (phospho-ERK),
ERK2, and phosphorylated stress-activated protein kinase-2 (phospho-
p38) were obtained from New England Biolab (Beverly, MA), and
phosphorylated c-jun N-terminal kinase (phospho-JNK) from Santa Cruz
Biotechnology (Santa Cruz, CA).
Cell culture Normal human keratinocytes isolated from neonatal
foreskin epidermis were prepared and cultured following the methods
described previously (Fang et al, 1998). Cells were cultured in serum-free
Medium-154 (Cascade Biologics, Portland, OR) supplemented with
human keratinocyte growth supplement (HKGS, containing 0.2 ng EGF
per ml, 5 mg insulin per ml, 5 mg transferrin per ml, 0.18 mg
hydrocortisone per ml, and 0.2% bovine pituitary extract). The medium
contains 0.2 mM Ca2þ , 28 mM HEPES, antibiotics, and anti-mycotics
(penicillin, streptomycin, and amphotericin). Cultures were kept at 371C
in a humidi¢ed atmosphere of 5% CO2. Passage 4^6 cells were used for
all experiments. For some experiments, cells were cultured overnight in
the basal Medium-154, free of Ca2þ and free of the HKGS supplement
(Medium-154CF).
Cell migration assay The migration of normal human keratinocytes
was assayed using a computer-assisted videomicroscopy system established
previously in our laboratory (Fang et al, 1998) with a minor modi¢cation.
Brie£y, 35 mm tissue culture dishes were coated with 30 mg collagen per ml
(Vitrogen, Collagen Corp, Palo Alto, CA) in phosphate-bu¡ered saline,
and rinsed with Medium-154. Cells were plated in the collagen-coated
dishes at a density of 105 cells per dish in Medium-154/HKGS. After a 2^6
h incubation, dishes were rinsed once with the medium to remove
unattached cells and fresh Medium-154/HKGS or other medium was
added, as indicated in Results. After continued incubation for 1 h, cells
were treated with test agents. The culture dish was placed on a warmed
microscope stage set at 371C and cell migration was monitored using
time-lapse computer-controlled videomicroscopy. For each experiment, a
¢eld containing 20^30 single cells was selected, and frames were captured
every 10 min for total of 1 h. Migration distance (mm) and rate (mm per
min) of each individual cell were calculated with an Apple-scripted
program using NIH Image 1.60 and FileMaker Pro 3.0, as we have
previously described (Fang et al, 1998).
cAMP assay Intracellular cAMP levels were determined using the
cAMP enzyme immunoassay (EIA) kit (Amersham Pharmacia Biotech,
Piscataway, NJ). Brie£y, normal human keratinocytes were plated in
collagen-coated 24-well culture plates in Medium-154/HKGS at a density
of 8^12104 cells per well. After incubation 3 h or overnight (with a
change of medium once at 1.5 h to remove unattached cells), cells were
treated with test agents as described in Results. The treatment was
terminated by the aspiration of the culture medium and the addition of the
lysis bu¡er included in the kit. cAMP was measured using the
nonacetylation assay procedure provided by the manufacturer. The mean
cell number in each well was determined by trypsinization and counting in
four replicate wells. The cAMP level was expressed as fmol per 1000 cells.
Western blot analysis of activated MAP kinases Normal human
keratinocytes were plated in collagen-coated 60 mm dishes (using the
same coating condition as described in Migration Assay) at 5105 cells per
dish. After 3 h to overnight incubation in medium-154/HKGS (changed
once at 1.5 h with the same medium), cells were pretreated or treated with
test agents as described in the ¢gure legends. Reactions were terminated by
transferring dishes on to ice, removing medium, and immediately adding
lysis bu¡er [20 mM Tris, pH 7.4, 1% Triton X-100, 150 mM NaCl, 10%
glycerol, 50 mM b-glycerophosphate, 1 mM ethylenediamine tetraacetic
acid, 1 mM ethyleneglycol-bis-(b-aminoethylether)-N,N,N0,N0-tetraacetic
acid, 10 nM okadaic acid, 1 mM sodium orthovanadate, 1 mM
phenylmethylsulfonyl £uoride, and 10 mg per ml of aprotinin and
leupeptin]. The lysates were cleared by centrifugation at 12,000 g for
10 min at 41C. Equal amounts of lysate proteins, typically 10 mg, were
fractionated on a 10% sodium dodecyl sulfate^polyacryamide gel and
then transferred on to PVDF membrane (Millipore Co., Bedford, MA).
Membranes were blocked with 5% nonfat milk in TBST (10 mM Tris, pH
7.6, 150 mM NaCl, 0.1% Tween 20) for 1 h at room temperature or
overnight at 41C. The blots were incubated with anti-phospho-ERK (1 :
1000) or anti-phospho-p38 (1 : 5000), or anti-phospho-JNK (1 : 2000)
antibodies at 41C overnight or at room temperature for 2 h. After
incubation with the corresponding horseradish peroxidase-conjugated
secondary antibody, the phospho-MAP kinases on the membranes were
detected with ECL Plus chemiluminescence (NEN Life Science Products,
Boston, MA) and direct exposure to Hyper¢lm (Amersham Pharmacia
Biotech). For normalization of protein loading for each sample, the blots
were reprobed with antibody against nonphosphorylated kinase to detect
total protein.
Statistical analysis The means of control and treatment groups were
compared using Student’s t test or ANOVAwhere indicated in the Results or
¢gure legends, with signi¢cance described at po0.05.
RESULTS
Inhibition of human keratinocyte migration by isoproterenol
The migration rate of human keratinocytes was measured in cells
cultivated at 371C in Medium-154/HKGS containing various
concentrations of isoproterenol, a b-adrenergic receptor agonist.
Isoproterenol treatment signi¢cantly decreased the migration
rate in a concentration-dependent manner (Fig 1). Isoproterenol
at 10 nM resulted in a maximal inhibition of migration,
demonstrating an 80% decrease in migration rate as compared
with untreated cells. Statistically signi¢cant inhibition of
migration was also observed when the cells were exposed to
isoproterenol at concentrations as low as 0.01 nM. Pretreatment of
the human keratinocytes with timolol (20 mM for 15 min at 371C),
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a b-adrenergic receptor antagonist, completely prevented the
isoproterenol-induced inhibition of migration (Fig 2). This
suggests that isoproterenol-induced inhibition of keratinocyte
migration is mediated by activation of b-adrenergic receptors.
The HKGS supplement added to the Medium-154 routinely
used in our migration assays contains several components,
including EGF and Ca2þ , both of which can stimulate
keratinocyte migration (Fang et al, 1998; Hudson and McCawley,
1998). In order to determine if b-adrenergic receptor-mediated
inhibition of keratinocyte migration was speci¢c for either EGF
or Ca2þ -stimulated migration, we assayed cell migration in basal
Medium-154, without HKGS supplementation, to which either
EGF or Ca2þ were separately added. In the absence of both
EGF and Ca2þ from the assay medium (the cells were made
quiescent overnight), keratinocytes migrated at a rate of about
0.2 mm per min (Fig 3). Addition of either Ca2þ (1.8 mM) or
EGF (10 ng per ml) to the culture medium increased the
migration rate by 4-fold. Isoproterenol (100 nM) completely
inhibited either EGF or Ca2þ -stimulated cell migration.
Isoproterenol did not alter the minimal migration observed in
cells maintained in the basal medium that did not contain
growth factors or Ca2þ .
b-adrenergic receptor-mediated inhibition of migration is
independent of increased intracellular cAMP concentra-
tions In human keratinocytes, b-adrenergic receptors activate
adenylyl cyclase resulting in increased intracellular cAMP
concentrations (Orenberg et al, 1983).We examined whether the
adenylyl cyclase/cAMP signaling pathway accounted for b-
adrenergic receptor-induced inhibition of human keratinocyte
migration. The cells were pretreated with either of two adenylyl
cyclase inhibitors, namely DDA and SQ22536, before cell
migration was assayed in the presence of isoproterenol.
Pretreatment with either inhibitor alone did not alter
keratinocyte migration under basal conditions nor did either of
these compounds prevent the inhibition of migration induced
by isoproterenol (Fig 4A). As expected, however, both of these
adenylyl cyclase inhibitors signi¢cantly decreased intracellular
cAMP accumulation stimulated by isoproterenol (Fig 4B). These
results suggest that isoproterenol-mediated inhibition of cell
migration may involve cAMP-independent mechanisms.
The inhibition of isoproterenol-stimulated cAMP accumu-
lation by DDA and SQ22536 was partial. As there can be a large
redundancy in cAMP signaling pathways, for example as has
been demonstrated in adipocytes (Ho¡man et al, 1989), it is
possible that even the small cAMP response to isoproterenol in
the presence of adenylyl cyclase inhibitors, could be su⁄cient
to inhibit cell migration. Consequently, to test further the
hypothesis that b-adrenergic receptor-mediated inhibition of
migration of human keratinocytes was independent of increased
cAMP concentrations, we asked whether forskolin, a well-known
activator of adenylyl cyclase activity, could inhibit migration of
Figure1. The b-adrenergic receptor agonist isoproterenol inhibits
human keratinocyte migration in a concentration-dependent
manner. Human keratinocytes were plated on collagen-coated dishes in
serum-free Medium-154/HKGS 2^4 h prior to treatment with 0^1000 nM
of isoproterenol for 15 min. Cell migration was monitored using a time-
lapse computer-assisted videomicroscopy at 371C, as described in Materials
and Methods. The migration rate of the control, untreated cells was 0.85 7
0.19 mm per min, which was taken as 100% (baseline). The data, expressed
as percentage of control (untreated cells), are mean7SD of 60^100 cells
from two to four separate experiments, #po0.05 and npo0.01 with Stu-
dent’s t test as compared with control (untreated) cells.
Figure 2. The b-adrenergic receptor antagonist timolol reverses iso-
proterenol-induced inhibition of human keratinocyte migration.
Human keratinocytes were cultured in serum-free Medium-154/HKGS as
described in Fig 1. The cells were pretreated with 20 mM timolol or its sol-
vent H2O for 15 min, followed by stimulation with 100 nM isoproterenol
for 15 min. The migration was monitored with computer-assisted time-
lapse videomicroscopy as described in Fig 1. The cell migration rate was
analyzed and expressed as mm per min. The data are mean7SD of 60^100
cells from three to four separate experiments. npo0.01, compared with
either control or timolol plus isoproterenol groups.
Figure 3. Isoproterenol inhibits both EGF- and Ca2+-induced
human keratinocyte migration. Human keratinocytes were cultured as
shown by Figs 1 and 2, followed by rinsing three times with Ca2+ free and
HKGS-free medium (Medium-154CF). The cells were quiescent overnight
(about 20 h) in Medium-154CF and then treated with EGF (10 ng per ml)
or Ca2+ (1.8 mM) or untreated (Control) for 10 min followed by treatment
with 100 nM isoproterenol or H2O (vehicle) for 15 min. The cell migration
was monitored as described in Fig 1. The data are mean 7 SD of 60^70
cells from two separate experiments.
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these cells. As shown in Fig 5, forskolin (1 mM) markedly
increased the intracellular concentration of cAMP, whereas a low
concentration of isoproterenol (1 nM) did not measurably increase
intracellular cAMP concentrations, compared with untreated
control cells. Interestingly, forskolin did not signi¢cantly inhibit
cell migration, whereas there was a readily measured e¡ect of
isoproterenol on the migration of these cells. This apparent
dissociation between inhibition of keratinocyte migration and
intracellular cAMP concentrations supports the hypothesis that
the cAMP signaling pathway does not play an important part
in the inhibition of keratinocyte migration induced by
the activation of b-adrenergic receptors.
As indicated above, we found that extracellular Ca2þ increased
the migration rate of human keratinocytes. We also found that
extracellular Ca2þ increased intracellular cAMP accumulation
(Fig 6). Preincubation of the cells with DDA or SQ22536
completely inhibited the extracellular Ca2þ induced increase in
cAMP accumulation but had no signi¢cant e¡ects on the
migration rate (Fig 6). These results lend further support to
the hypothesis that cAMP is not an important regulator of
migration rate in human keratinocytes.
b-adrenergic receptor activation selectively inhibits MAP
kinase independent of intracellular cAMP concentra-
tions Members of MAP kinase family, ERK, JNK, and p38,
are part of the signal transduction pathway initiated by growth
factors, cytokines, and adhesion molecules (Rousseau
et al, 1997; Force and Bonventre, 1998; Hudson and McCawley,
1998; Leng et al, 1999; Glading et al, 2000). Activation of MAP
kinases may lead not only to mitogenesis but also to
motogenesis (Kundra et al, 1994; Yenush et al, 1994; Klemke et al,
1997; Nguyen et al, 1999). To investigate whether inhibition of
migration induced by b-adrenergic receptor stimulation is
associated with the alteration of MAP kinase activity, we
measured activities of ERK, JNK, and p38 MAP kinases in
human keratinocytes as indicated by phosphorylation of each of
these kinases (Pearson et al, 2001). In the presence of EGF and
Ca2þ , isoproterenol inhibited phosphorylation of ERK in a
concentration-dependent manner (Fig 7), but had no signi¢cant
e¡ect on JNK and p38 phosphorylation. The inhibition of ERK
phosphorylation by isoproterenol was prevented by pretreatment
of the cells with timolol (Fig 8A). Treatment of the cells
with forskolin increased cAMP accumulation comparably with
isoproterenol (Fig 8B). Nonetheless, neither forskolin nor CPT-
cAMP, 8-(4 -chlorophenylthio)adenosine-30,50 -cyclic monophos-
phorylkated, RP-isomer a cell-permeable cAMP analog,
inhibited ERK phosphorylation: indeed, these compounds may
have slightly stimulated ERK phosphorylation (Fig 8A).
DISCUSSION
Whereas the capacity of growth factor and adhesion molecules to
mediate cell migration has been extensively studied, hormonally
or drug-mediated inhibitory e¡ects on cell migration and their
potential signaling mechanisms are much less understood. In this
study, we have demonstrated that activation of b-adrenergic re-
ceptors signi¢cantly inhibited keratinocyte migration in cells that
were stimulated to migrate either by growth factors or extra-
cellular Ca2þ . Furthermore, the data suggest that these promi-
nent inhibitory e¡ects are independent of increased intracellular
cAMP accumulation promoted by the activation of these
Figure 4. Isoproterenol-mediated inhibition of human keratinocyte
migration is independent of adenylate cyclase activity.The cells were
cultured as described in Fig 1, and pretreated with 100 mM DDA, or 100 mM
SQ22536 or dimethyl sulfoxide for 30 min at 371C, followed by 10 nM iso-
proterenol for 15 min. (A) The cell migration was measured as described in
Fig 1. The data of migration rate (mm per min) are mean7SD of 50^100
cells from three to four separate experiments. npo0.01 comparing isopro-
terenol-treated cells with corresponding control cells. (B) Intracellular
cAMP levels, measured with a cAMP EIA system, as described in Materials
and Methods, expressed as fmol cAMP per 1000 cells. The data are
mean7SD of two to four separate experiments. npo0.01 and #po0.05,
comparing DDA- or SQ22536-pretreated cells with dimethyl sulfoxide
control in isoproterenol groups.
Figure 5. Dissociation of isoproterenol-induced inhibition of
human keratinocyte migration from intracellular cAMP level. The
human keratinocytes, as described in Fig 1, were treated with 1 nM isopro-
terenol, or 1 mM forskolin, or untreated for 15 min. Left panel: cell migration
was assayed and analyzed as described in Fig 1. The data of migration rate
(mm per min) are mean7SD of 32^100 cells from three to four separate
experiments. #po0.05, compared with control cells, and no statistically
signi¢cant di¡erence between control and forskolin-treated cells. Right pa-
nel: intracellular cAMP levels, measured with cAMP EIA system, expressed
as fmol cAMP per 1000 cells. The data are mean7SD of two to four sepa-
rate experiments. npo0.01 compared with control cells, and no statistically
signi¢cant di¡erence between isoproterenol-treated and control cells.
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receptors. The mechanism underlying the negative regulation of
migration by b-adrenergic receptors in keratinocytes is presently
unknown but appears to be associated with selective attenuation
of ERK MAP kinase phosphorylation.
There are ¢ve lines of evidence in this study to support these
major conclusions: (i) isoproterenol-induced inhibition of kerati-
nocyte migration was completely prevented by timolol, a b-adre-
nergic receptor antagonist; (ii) adenylyl cyclase inhibitors
inhibited isoproterenol-induced increase in intracellular cAMP
concentrations but had no e¡ect on migration; (iii) the adenylyl
cyclase activator forskolin dramatically increased intracellular
cAMP concentration, without, however, inhibiting cell migra-
tion; (iv) extracellular Ca2þ stimulated an increase in intracellu-
lar cAMP concentrations; when this was prevented by adenylyl
cyclase inhibitors, the Ca2þ induced migration rate of the cells
was unchanged; and (v) b-adrenergic receptor activation-induced
decrease in ERK MAP kinase phosphorylation was not mi-
micked by the adenylyl cyclase activator forskolin nor by a mem-
brane permeable cAMP analog.Thus, it is likely that b-adrenergic
receptors utilize a novel signaling pathway to regulate keratino-
cyte migration.
b-adrenergic receptors were identi¢ed in human keratinocytes
about two decades ago (Harper and Flaxman, 1975; Orenberg
et al, 1983). Early studies suggested that b-adrenergic receptor ago-
nists, such as isoproterenol, inhibited migration of newt keratino-
cytes (Dunlap, 1980; Donaldson and Mahan, 1984) and mitosis
of human keratinocytes (Harper and Flaxman, 1975), while
also increasing intracellular cAMP concentrations in these cells.
Subsequent studies, however, failed to con¢rm a causal relation-
ship between the increase in intracellular cAMP and inhibition of
cell migration in either human (Iwasaki et al, 1994) or newt kera-
tinocytes (Dunlap and Donaldson, 1980; Dunlap, 1980; Donald-
son et al, 1984). The complexity of this question is illustrated by
the fact that in neutrophils, increased cAMP accumulation stimu-
lates migration in response to endothelin (Elferink and de Koster,
1998) and N-formyl-methonyl-leucyl-phenylalanine (Spisani et al,
1996) or else has no e¡ect on cell migration (Neptune and
Bourne, 1997).
We found that activation of the b-adrenergic receptor by iso-
proterenol both increased intracellular cAMP concentrations and
inhibited keratinocyte migration in a concentration-dependent
manner. Adenylyl cyclase inhibitors signi¢cantly decreased intra-
cellular cAMP concentrations but did not prevent the inhibition
of keratinocyte migration induced by isoproterenol. That isopro-
terenol inhibited migration independently of cAMP was further
supported by the fact that forskolin-stimulated an increase
in intracellular concentrations of cAMP yet had no signi¢cant
inhibitory e¡ects on migration. Further, isoproterenol at a
concentration of 1 nM did not measurably increase intracellular
concentrations of cAMP, yet induced a 50% inhibition of migra-
tion. Recent evidence indicates that cAMP signaling can be
localized to intracellular microdomains (Rich et al, 2000), and
Figure 6. Ca2+-stimulated migration is independent of adenylate
cyclase activity in human keratinocytes. Human keratinocytes were
cultured in Medium-154/HKGS for 2 h, followed by rinsing three times
with Ca2+-free medium and HKGS-free medium (Medium-154CF), as de-
scribed at Fig 3. After incubation in Medium-154CF overnight, the cells
were pretreated with 100 mM DDA or SQ22536 or dimethyl sulfoxide for
30 min, then treated with Ca2+ (1.8 mM) for 15 min. (A) Cell migration
rates, expressed as mm per min, are mean7SD of 50^60 cells from two
separate experiments. #po0.05 between control and Ca2+ treatment. (B)
Intracellular cAMP levels were measured with cAMP Direct EIA kit, ex-
pressed as fmol cAMP per 1000 cells. The data are mean7SD of two sepa-
rate experiments. #po0.05, between DDA- or SQ22536-, and dimethyl
sulfoxide-pretreated cells in Ca2+ groups.
Figure 7. The b-adrenergic receptor agonist isoproterenol inhibits
ERK MAP kinase, but not p38 and JNK MAP kinases in human
keratinocytes. Human keratinocytes were cultured in Medium-154/
HKGS in collagen-coated dishes, as described in Fig 1. Cells were stimu-
lated with various concentrations of isoproterenol (0^100 nM) for 15 min.
Reactions were terminated by aspiration of medium and rinsed with ice-
cold phosphate-bu¡ered saline, followed by the addition of lysis bu¡er.Ten
micrograms of lysate protein from each sample were subjected to polyacry-
lamide gel electrophoresis and immunoblotting using speci¢c antibodies
against phospho-ERK (p-ERK) or unphosphorylated ERK2 (A), phos-
pho-JNK (p-JNK) (B), and phospho-p38 (p-p38) (C).
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therefore measurements of global changes in cAMP may not ac-
curately re£ect microdomain changes that are important in sig-
naling; however, as forskolin e¡ectively activates all adenylyl
cyclase isoforms and increases both total and local microdomain
levels of cAMP (Taussig and Gilman, 1995; Rich et al, 2001;
Schwartz, 2001), yet does not inhibit migration, microdomain
changes in cAMP do not appear to mediate the observed e¡ect.
Taken together, these data suggest that it is very unlikely that the
b-adrenergic receptor-mediated inhibitory e¡ects on human
keratinocyte migration are mediated through the Gsa/cAMP
pathway.
A number of motogenic signaling components that converge
on the cytoskeletal migratory system and consequently regulate
cell locomotion in response to growth factors, cytokines, and ad-
hesion molecules have been identi¢ed. Two opposing motogenic
signaling pathways have recently been characterized (Cho and
Klemke, 2000; Klemke et al, 1997; Nguyen et al, 1999; Kain and
Klemke, 2001): namely, a stimulatory pathway involving the
ERK/MLCK cascade and an inhibitory pathway that utilizes
Abl tyrosine kinase-mediated phosphorylation to uncouple
CAS-Crk. Appropriate migration rate and direction are physiolo-
gically balanced by these positive and negative controls. In patho-
logic conditions, however, this balance can be disturbed and thus
impair migration. The b-adrenergic receptor-mediated inhibition
of keratinocyte migration observed in this study could be due to
inactivation of the positive control signaling and/or activation of
the negative control pathway.
We found that growth factor-induced phosphorylation of
ERK but not JNK and p38 MAP kinases was inhibited by acti-
vation of b-adrenergic receptors. This suggests that b-adrenergic
receptors may likely impact the positive control pathway. Ele-
ments signaling upstream of ERK MAP kinase activation could
be inactivated by b-adrenergic receptor-mediated transducers.
These include tyrosine kinases (receptor and nonreceptor),
MEK, Ras/Raf, protein kinase C, phosphatidylinositol-3 kinase,
and others (Lopez-Ilasaca et al, 1997; Force and Bonventre, 1998;
Lopez-Ilasaca, 1998; Cobb, 1999; Pearson et al, 2001; Qi et al,
2001). On the other hand, it is also possible that b-adrenergic re-
ceptor signaling dephosphorylates and inactivates phospho-ERK
MAP kinases in human keratinocytes through the activation of
protein phosphatases. Phosphorylation of tyrosine and subse-
quent threonine residues in the active site of ERK MAP kinases
is required for ERK activation (for review see Pearson et al, 2001).
The removal of one or both these phosphates by tyrosine, serine/
threonine, or dual-speci¢city MAP kinase phosphatases can sig-
ni¢cantly reduce ERK MAP kinase activity (Keyse, 2000; Pear-
son et al, 2001). Increasing evidence suggests that protein
phosphatases, particularly protein tyrosine phosphatases, play the
same important part as protein kinases in the regulation of cell
adhesion and migration (Angers-Loustau et al, 1999a,b). The iden-
tities of the protein phosphatases that are downstream of b-adre-
nergic receptors are presently unknown. A previous study has
demonstrated, however, that cantharidin, an inhibitor of protein
phosphatase types 1 and 2A, signi¢cantly attenuated isoprotere-
nol-induced cAMP-independent vasorelaxation of bovine coron-
ary artery rings in vitro (Knapp et al, 1997). Recently, another
study showed that inhibition of protein tyrosine phosphatases
by vanadate compounds signi¢cantly inhibited isoproterenol-in-
duced L-type Ca2þ channel activity in guinea pig ventricular
myocytes through a cAMP-independent pathway (Sims et al,
2000). These observations suggest that protein phosphatases are
likely to be involved in the intracellular signal transduction sti-
mulated by b-adrenergic receptors.
In many other cell types, stimulation of b-adrenergic receptors
increases ERK MAP kinase activity in either a cAMP/PKA-de-
pendent or cAMP/PKA-independent manner (Crespo et al, 1995;
Daaka et al, 1997;Wan and Huang, 1998), in part involving tyro-
sine kinases (Luttrell et al, 1999b; Cao et al, 2000). For example,
in transfected COS-7 cells ERK activation is mediated by bg
subunits of G-protein and is independent of cAMP (Crespo et al,
1995), whereas PKA-dependent phosphorylation of the b-adre-
nergic receptor is required for ERK MAP kinase activation in
HEK293 cells (Daaka et al, 1997). On the other hand, Gsa is re-
sponsible for transducing the b-adrenergic receptor signal to
MAP kinase in a cAMP/PKA-dependent manner in S49 mouse
lymphoma cells (Wan and Huang, 1998). Thus, the ¢nding of b-
adrenergic receptor agonist-mediated inhibition of ERK MAP
kinase activity is unique for keratinocytes.
There is increasing evidence that b-adrenergic receptors play
important physiologic and pathologic roles in many cell types
using pathways other than the initially identi¢ed Gsa/adenylate
cyclase pathway. Signaling may be through either Gsbg subunits,
di¡erent G-proteins or e¡ectors other than G-proteins, such as b-
arrestin (for review see Lefkowitz, 1998; Brzostowski and Kim-
mel, 2001). For example, the b-adrenergic receptor regulation of
intracellular pH is independent of G-protein activation, and is
mediated through agonist-promoted association of the receptors
with the Naþ/Hþ exchanger regulatory factor (Hall et al, 1998).
In our study, pertussis toxin pretreatment did not alter e¡ects of
isoproterenol on keratinocyte migration (data not shown) sug-
gesting that pertussis toxin-sensitive G-protein is unlikely in-
volved in b-adrenergic receptors-induced e¡ects on keratinocyte
migration. Certainly, further detailed pharmacologic and mole-
cular characterization of b-adrenergic receptors will help us better
understand the mechanisms that underlie b-adrenergic receptor-
regulated motogenesis as well mitogenesis in human keratino-
cytes.
In summary, these data demonstrate that b-adrenergic receptors
negatively regulate keratinocyte migration stimulated by growth
factors or Ca2þ through a cAMP-independent pathway that may
involve inhibition of ERK MAP kinase phosphorylation. As b-
adrenergic receptor agonists and antagonists are widely used to
treat asthma and hypertension, these drugs may be altering the
Figure 8. Isoproterenol-induced inhibition of ERK MAP kinase is
completely reversed by timolol, but is independent of intracellular
cAMP level. Human keratinocytes were cultured in Medium-154/HKGS
in collagen-coated dishes, as described at Fig 1. Cell were pretreated with
or without timolol (10 mM, 15 min) followed by treatment with isoproter-
enol (10 nM, 15 min) at 371C. In separate experiments, cells were treated for
15 min at 371Cwith 10 mM forskolin (F) or 1mM CPT-cAMP (C), a plasma
membrane permeable cAMP analog. (A) Western blot analysis of phospho-
ERK, as described in Fig 7. The data shown are representative of two in-
dependent experiments. (B) Intracellular cAMP measurement, as described
in Fig 4. The data are mean7SD from two experiments performed in
duplicate.
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wound healing ability of a large group of patients. Understand-
ing the checkpoints responsible for the positive and negative con-
trol of motogenesis will help us better understand the signaling
mechanisms of migration required for wound healing, as well as
o¡er sound rationales for developing target-speci¢c drugs to
enhance this process.
J.C. is a Recipient, Fellowship for Careers in Clinical Pharmacology from Pharma-
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